{"title":"一种用于经口无切口手术的新型革命性手术设备:EsophyX™用于患有反流疾病的患者的腔内底扩张(ELF)","authors":"Adrian Lobontiu, D. Loisance","doi":"10.1109/AT-EQUAL.2009.13","DOIUrl":null,"url":null,"abstract":"The novel Endoluminal Fundoplication (ELF) technique using a Trans-Oral Incisionless and fastener-deploying device (EsophyX™, EndoGastric Solutions) was developed and evaluated for feasibility, safety and the treatment of Gastro-Esophageal Reflux Disease (GERD) in a series of animal and human (phase 1, phase 2) studies.","PeriodicalId":407640,"journal":{"name":"2009 Advanced Technologies for Enhanced Quality of Life","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Novel Revolutionary Surgical Device for TransOral Incisionless Surgery: EsophyX™ Used for Endoluminal Fundoplication (ELF) in Patients Suffering of Reflux Disease\",\"authors\":\"Adrian Lobontiu, D. Loisance\",\"doi\":\"10.1109/AT-EQUAL.2009.13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The novel Endoluminal Fundoplication (ELF) technique using a Trans-Oral Incisionless and fastener-deploying device (EsophyX™, EndoGastric Solutions) was developed and evaluated for feasibility, safety and the treatment of Gastro-Esophageal Reflux Disease (GERD) in a series of animal and human (phase 1, phase 2) studies.\",\"PeriodicalId\":407640,\"journal\":{\"name\":\"2009 Advanced Technologies for Enhanced Quality of Life\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2009 Advanced Technologies for Enhanced Quality of Life\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/AT-EQUAL.2009.13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2009 Advanced Technologies for Enhanced Quality of Life","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/AT-EQUAL.2009.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Novel Revolutionary Surgical Device for TransOral Incisionless Surgery: EsophyX™ Used for Endoluminal Fundoplication (ELF) in Patients Suffering of Reflux Disease
The novel Endoluminal Fundoplication (ELF) technique using a Trans-Oral Incisionless and fastener-deploying device (EsophyX™, EndoGastric Solutions) was developed and evaluated for feasibility, safety and the treatment of Gastro-Esophageal Reflux Disease (GERD) in a series of animal and human (phase 1, phase 2) studies.